Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. May 7, 2014; 20(17): 4963-4971
Published online May 7, 2014. doi: 10.3748/wjg.v20.i17.4963
Published online May 7, 2014. doi: 10.3748/wjg.v20.i17.4963
Figure 2 Effects of anti-tumor necrosis factor-α antibody on caspase-3 activation and apoptosis.
Rats were treated as described above. A: Caspase-3 activation. Livers were lysed in lysis buffer and caspase-3 activation was measured. bP < 0.01 vs controls; dP < 0.01 vs LPS + IgG (n = 10); B: Liver apoptosis was examined using dUTP nick end labeling assay in rats 9 h after injection with control (saline + IgG), LPS + IgG or LPS + anti-TNF-α. Bar: 100 μm; C: Apoptosis index in the different groups. bP < 0.01 vs control; dP < 0.01 vs LPS + IgG (n = 10). TNF-α: Tumor necrosis factor-α; LPS: Lipopolysaccharide.
- Citation: Fan JH, Feng GG, Huang L, Tang GD, Jiang HX, Xu J. Naofen promotes TNF-α-mediated apoptosis of hepatocytes by activating caspase-3 in lipopolysaccharide-treated rats. World J Gastroenterol 2014; 20(17): 4963-4971
- URL: https://www.wjgnet.com/1007-9327/full/v20/i17/4963.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i17.4963